These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 6178228)

  • 41. [Electrophysiological effects of the new antiarrhythmic drug flecainide (R 818) in man (author's transl)].
    Seipel L; Abendroth RR; Breithardt G
    Z Kardiol; 1981 Jul; 70(7):524-9. PubMed ID: 7269731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of complex ventricular arrhythmias by oral flecainide.
    Duran D; Platia EV; Griffith LS; Adhar G; Reid PR
    Clin Pharmacol Ther; 1982 Nov; 32(5):554-61. PubMed ID: 7127996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of pentisomide on stable ventricular premature beats. Comparison with placebo.
    Mangini SG; Mastropasqua F; Oldani V; Massari F; Maino GN; Ricci A; Scrutinio D; Rizzon P
    Eur Heart J; 1991 Jun; 12(6):712-9. PubMed ID: 1713557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Anti-arrhythmic effect of tocainide (lidocaine congener) on ventricular arrhythmias (author's transl)].
    Kuck KH; Hanrath P; Lubda J; Mathey D; Bleifeld W
    Dtsch Med Wochenschr; 1979 Nov; 104(48):1701-5. PubMed ID: 93043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Dose-dependent anti-arrhythmia effect of retard metoprolol in coronary disease patients with ventricular arrhythmia].
    Hartwig CA; Bethge KP; Wenzlaff P; Lichtlen PR
    Z Kardiol; 1988 Nov; 77(11):704-12. PubMed ID: 2463717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative study of the anti-arrhythmia effect of flecainide acetate and prajmalium bitartrate in patients with tachycardiac ventricular rhythm disorders].
    Andresen D; von Leitner ER; Wegscheider K; Theiss A; Agena H; Schröder R
    Z Kardiol; 1986 Jul; 75(7):394-401. PubMed ID: 2429466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; ten Cate FJ; Jovanovic A; Hagemeijer F; Withagen A; Polak BC; Roelandt J; Hugenholtz PG
    Eur Heart J; 1984 Oct; 5(10):814-23. PubMed ID: 6499854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The effectiveness of barucainide in supraventriculr and ventricular arrhythmias].
    Brugger P
    Z Kardiol; 1989 Aug; 78(8):510-8. PubMed ID: 2477959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Intravenous flecainide administration for conversion of paroxysmal atrial fibrillation in the emergency room].
    Antonelli D; Feldman A; Freedberg NA; Darawsha A; Rosenfeld T
    Harefuah; 2006 May; 145(5):342-4, 398. PubMed ID: 16805213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Anti-arrhythmia effect of long-term encainide in chronic ventricular extrasystole].
    Dumoulin P; Jaillon P; Kher A; Poirier JM; Cheymol G; Valty J; Flammang D; Coumel P; Medvedowsky JL; Barnay C
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():105-9. PubMed ID: 2420299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Electrophysiological changes of the excitoconduction system in patients with Chagas cardiomyopathy and their modification by flecainide].
    Abitbol HF; Carrizo Paez R; Derlis Abate C
    Arch Inst Cardiol Mex; 1988; 58(2):107-14. PubMed ID: 2456750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Mexiletine in the treatment of ventricular arrhythmias (author's transl)].
    Schlemmer M; Wimmer M
    Padiatr Padol; 1982; 17(2):383-9. PubMed ID: 6179031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antiarrhythmic therapy with flecainide in acute experimental myocardial infarction (author's transl)].
    Gülker H; Bender F; Brisse B; Thale J; Heuer H; Kristek J; Schindelhauer F; Teerling K
    Z Kardiol; 1981 Feb; 70(2):124-30. PubMed ID: 7222906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Depression of diurnal dispersion of sinus rhythm in patients after myocardial infarct].
    Kaliuzhin VV; Tepliakov AT; Maleeva MA; Pushnikova EIu; Solovtsov MA
    Ter Arkh; 2000; 72(9):44-7. PubMed ID: 11076416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Relationship between late ventricular potentials and ventricular arrhythmias in patients in chronic dialysis treatment].
    Pomini G; Salvo P; Torchiarella C; Lucangeli A; Ruffatti A; Naso A; Gribaldo R
    Minerva Cardioangiol; 1997 Apr; 45(4):155-65. PubMed ID: 9213830
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Spontaneous variability of ventricular extrasystole in chronic Chagas cardiopathy].
    Grupi CJ; Sosa EA; De Carvalho JF; Antonelli RH; Bellotti G; Pileggi F
    Arq Bras Cardiol; 1991 Jun; 56(6):445-50. PubMed ID: 1726676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effective dose of flecainide for arrhythmia in children].
    Sumitomo N; Ushinohama H; Hara M; Otuka M; Harada K; Okuni M
    Kokyu To Junkan; 1993 Nov; 41(11):1079-82. PubMed ID: 8256048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.